Skip to main content
. 2023 Jan 13;15(2):502. doi: 10.3390/cancers15020502
CAA cancer-associated adipocyte
TME tumor microenvironment
COX-2 cyclooxygenase-2
NSAID nonsteroidal anti-inflammatory drug
FA fatty acid
BMI body mass index
PG prostaglandin
PPAR peroxisome proliferator-activated receptor
C/EBP CCAAT enhancer binding protein
IL interleukin
TNFα tumor necrosis factor α
FFA free fatty acid
FAO fatty acid oxidation
TG triacylglycerol
MMP matrix metalloproteinase
CCL2 chemokine ligand 2
VEGF vascular endothelial growth factor
ECM extracellular matrix
EMT epithelial-mesenchymal transition
IGF insulin-like growth factor
IGFBP IGF binding protein
AP1 activator protein-1
MSC mesenchymal stem cell
CiDA compression-induced dedifferentiated adipocytes
LPS liposarcoma
AP2 adipocyte protein 2
TGFβ transforming growth factor β
MCP1 monocyte chemoattractant protein-1
PPRE PPAR response element
PLIN1 perilipin1
HSL hormone sensitive lipase
CCR2 C-C chemokine receptor type 2
cAMP cyclic AMP
PKA protein kinase A
ATGL adipose triglyceride lipase
JAK Janus kinase
STAT signal transducer and activator of transcription
EV extracellular vesicle
FAP familial adenomatous polyposis
OR odds ratio
CI confidence interval
HR hazard ratio